Promore Pharma AB, of Stockholm, filed a phase III trial application involving its most advanced asset, PXL01, for prevention of post-surgical adhesions after tendon repair surgery in the hand. Read More
Novelogics Biotechnology Inc., of Vancouver, British Columbia, said it cemented a research agreement with Canada's Centre for Drug Research and Development (CDRD) involving Novelogics' internally developed antibody immunotherapy for cancer. Read More
Saniona AB, of Copenhagen, said it issued 921,053 new shares at SEK38 through a private placement directed to a group of Swedish and international institutional investors, raising SEK35 million (US$3.99 million) before issue costs. Read More
KARACHI, Pakistan – Facing a chronic lack of regulation, the pharmaceutical industry in Pakistan is struggling to put in place a free market policy to boost the sector and provide quality drugs to a population of over 200 million. Read More
LONDON – A new analysis of the various pull mechanisms that have been suggested to de-risk antibiotic development concluded that the proposed $1 billion market entry awards are not large enough to revitalize the whole antibiotic supply chain. Read More
Though the debut of its stock was marred by the U.S. market's overall decline Wednesday, G1 Therapeutics Inc. priced an IPO to raise $105 million to advance lead candidates aimed at inhibiting cyclin-dependent kinases (CDKs). Read More
Despite "very interesting" preclinical data emerging on a heap of immuno-oncology molecules, "you still have to go into patients and show that it works," said Briggs Morrison, CEO of Syndax Pharmaceuticals Inc. "We went after patients with the biggest unmet need who are very hard to treat to try to demonstrate that we're actually seeing something in those patients. Not everybody has done that." Read More
Republicans and Democrats alike continue to circle the congressional wagons around the NIH, as the storm clouds of a proposed 24 percent budget cut gather overhead. Read More
